Author: Customer Service

Taipei, Taiwan, Oct. 10, 2025 (GLOBE NEWSWIRE) — YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that its business partner, EG Biomed US Inc. (“EG BioMed”) one of the Company’s licensing partners for pancreatic and breast cancer detection and with 3D Global to develop treatment for eye disorders, has been accredited by the College of American Pathologists’ (CAP) Laboratory Accreditation Program for its CLIA-certified laboratory in Bothell, Washington (CLIA Certificate #50D2316600). CAP accreditation, widely recognized as the gold standard in laboratory quality assurance, confirms that EG BioMed meets the highest standards of excellence in laboratory operations. Together with its existing...

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced that it has entered into definitive agreements for the purchase of an aggregate of 4,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.50 per share (or pre-funded warrant in lieu thereof) in a registered direct offering. The closing of the offering is expected to occur on or about October 13, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company...

MUSCATINE, Iowa, Oct. 10, 2025 (GLOBE NEWSWIRE) — On August 4, 2025, HNI Corporation (NYSE: HNI; “HNI” or “the Corporation”) announced a definitive agreement to acquire Steelcase, Inc. (NYSE: SCS; “Steelcase”) in a cash and stock transaction (the “Acquisition”). In connection with the Acquisition, HNI previously announced the commencement of an offer to exchange any and all outstanding 5.125% Notes due 2029 (the “Existing Steelcase Notes”), as issued by Steelcase, for up to $450,000,000 aggregate principal amount of new notes to be issued by HNI (the “New HNI Notes”). HNI today announced that it has received consents from Eligible Holders (as defined herein) representing 77.83% in principal amount of the Existing Steelcase Notes pursuant to HNI’s previously announced (A) offer to exchange (the “Exchange Offer”) any and all...

CULVER CITY, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced a series of cross-industry partnerships to expand visibility, diversify audiences, and drive long-term growth potential for upcoming indie titles, Above the Snow and Rebel Engine. Above the Snow, a cozy, story-rich shelter management sim set in the 1960s Alps, blends survival mechanics with character-driven storytelling and base-building. Building on its momentum after winning a NYX Award for best city builder, Above the Snow will also be showcased at the upcoming Poznan Game Arena October 24-26, 2025, one of the biggest gaming events in Eastern Europe. During the event, Above the Snow will unveil collaborations...

GLENVIEW, Ill., Oct. 10, 2025 (GLOBE NEWSWIRE) — Illinois Tool Works Inc. (NYSE: ITW) will issue its third quarter 2025 results on Friday, October 24, 2025, at 7:00 a.m. CDT. Following the release, ITW will hold its third quarter 2025 earnings webcast at 9:00 a.m. CDT. To access the webcast for the event, please click on the following link:ITW Q3 2025 Earnings Webcast If you are a participant on the conference call, please dial 1-888-660-6652 (domestic) or 1-646-960-0554 (international) 10 minutes prior to the 9:00 a.m. CDT start time. The passcode is “ITW.” Following the webcast, presentation materials and an audio webcast replay will be available at http://investor.itw.com. An audio-only replay will be available from October 24 through October 31 by dialing 1-800-770-2030 (domestic) or 1-609-800-9909 (international). The passcode...

CHICAGO, Oct. 10, 2025 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $500,000 worth of Ethereum (ETH), bringing its total investment in ETH to $1.5 million. This acquisition was executed pursuant to Cosmos Health’s previously announced $300 million digital assets facility, which is part of the Company’s broader strategic initiative to diversify its balance sheet and leverage blockchain technology within the healthcare and digital wellness sectors. Greg Siokas, CEO of Cosmos Health, stated: “We are pleased to continue our Ethereum purchases and reiterate our commitment to fully leveraging our $300 million financing facility. We are already seeing gains from our earlier...

LONG BEACH, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has signed a direct contract for two dedicated Electron launches with the Japan Aerospace Exploration Agency (JAXA) – signifying the criticality of Electron to international space agencies requiring responsive launch and dedicated access to space. Launching from Rocket Lab Launch Complex 1 in New Zealand, the two Electron missions will deploy satellites for JAXA’s Innovative Satellite Technology Demonstration Program. The first launch, scheduled from December 2025, will deploy the agency’s RApid Innovative payload demonstration SatellitE-4 (RAISE-4) spacecraft, a single satellite that will demonstrate eight technologies developed by private...

BRYCEVILLE, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) — Terrata Homes, a division of LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce the Grand Opening of Stables at Cary Forest, a boutique new construction neighborhood where timeless design and peaceful living come together. Located in Bryceville, Florida, and just a short drive from Jacksonville, this limited-release community offers homebuyers the combination of expansive acreage and modern convenience. The charm of Stables at Cary Forest lies in its exclusivity. With only ten homesites, the community offers a rare opportunity to build a life surrounded by space and privacy. At the same time, residents can enjoy the convenience of being close to shopping, dining, and everyday essentials in Jacksonville. Terrata Homes is introducing five impeccably designed floor plans ranging...

RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/. About CertaraCertara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies,...

HOUSTON, TX, Oct. 10, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, is excited to announce its participation in the upcoming 2025 Maxim Growth Summit on October 22nd at The Hard Rock Hotel NYC. This event brings together industry experts, innovators, and thought leaders to explore the latest trends and advancements across several industries. Attendees will have the opportunity to engage with Nexalin’s management team and learn about its proprietary, non-invasive neurostimulation — a drug-free, clinically proven treatment with the potential to scale worldwide. For additional information about the Maxim Growth Summit, or to register for the event, please click here. About Nexalin Technology, Inc. Nexalin...